# OnCo record nct06533826 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06533826/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06533826", "NCT06533826" ;
  schema:name "TRADE DXd"@en ;
  schema:alternateName "TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd"@en ;
  schema:description "TRADE DXd studies the order of two antibody-linked drugs, trastuzumab deruxtecan and datopotamab deruxtecan. It asks how well one works after the other stops controlling the cancer."@en ;
  schema:url <https://onco.cc/trials/nct06533826/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06533826>, <https://clinicaltrials.ucsf.edu/trial/NCT06533826> ;
  onco:status "recruiting" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2024-10-29" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/datopotamab-deruxtecan/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .